Comparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic Malignancy

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Comparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic Malignancy	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, myelodysplastic syndrome, neoplasm	Recruiting	Phase 2 / Phase 3	2026-08-05		NCT06895538

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Peking University First Hospital	225

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Peking University First Hospital	Beijing	China	71

Clinical trials